YD Bio Limited logo

YD Bio (YDES) stock

YDES · YD Bio Limited · NASDAQ

Market cap
$323.3M
P/E
Loss
EPS (FY)
-$0.12
Shares out
70.8M
52-week range20% up the range
$1.86$15.56

What is the latest news on YDES stock?

YDES fell 2.56% to $4.57 on Nov 19, 2026. No YDES story in the last two days; the most recent is below.

PRago
YD Bio Announces FDA Grant of INTERACT Meeting Request for YDB-LMSCEV-001, an Investigational Extracellular Vesicle Candidate for Dry Eye Disease

FDA agrees to provide written guidance by January 4, 2027, to support development of YDB-LMSCEV-001 TAIPEI, Taiwan, Nov. 12, 2026 (GLOBE NEWSWIRE) -- YD Bio Limited ("YD Bio" or the "Company") (NASDAQ:YDES), a biotechnology company advancing DNA methylation-based cancer detection and ophthalmologic innovations, today announced that the U.S. Food and Drug Administration (the "FDA") has granted its request for an INTERACT (INitial Targeted Engagement for Regulatory Advice on CBER/CDER ProducTs) meeting. Through this program, the FDA will provide early written regulatory feedback on YDB-LMSCEV-001, the Company’s investigational biologic eye drop for moderate-to-severe dry eye disease. This

All YDES news
Price$4.57+0.42 (+10.00%)
2026-08-192026-11-19

When does YD Bio report earnings?

The latest YD Bio earnings release came out on Aug 31, 2026: YD Bio Limited Reports Unaudited Financial Results for the Six Months Ended June 30, 2026. Before that, YD Bio reported on Apr 30, 2026.

YDES earnings history

Are insiders buying or selling YDES?

Insiders are buying. In the last 90 days 1 insider bought $129K of YDES in trades reported on Form 4. The latest: Ethan PhD Shen bought $49K, reported on Sep 16, 2026.

YDES insider trades

Financial highlights

Full financials
Revenue, FY2025
$596.8K
Revenue growth
+16.9%
Net income, FY2025
-$8.31M
Net margin
-1392.6%
Free cash flow, FY2025
-$8.04M
Cash
$6.01M

For fiscal 2025 (ended Dec 31, 2025), from SEC filings. Not investment advice.

Latest news

25 items
News · 26 weeks21-75%
2026-05-24: 12026-05-31: 12026-06-07: 02026-06-14: 02026-06-21: 02026-06-28: 32026-07-05: 02026-07-12: 02026-07-19: 12026-07-26: 12026-08-02: 12026-08-09: 32026-08-16: 02026-08-23: 12026-08-30: 12026-09-06: 22026-09-13: 12026-09-20: 02026-09-27: 02026-10-04: 32026-10-11: 02026-10-18: 12026-10-25: 02026-11-01: 02026-11-08: 12026-11-15: 0
2026-05-242026-11-15
Mix1090d
  • Insider5(50%)
  • Other4(40%)
  • Earnings1(10%)
Activity · 52 weeks5141 active days
Tap a day to see what happenedEarningsInsiderAnalystFilings and news

YD Bio Limited (YDES) is a Medical Specialities company listed on NASDAQ. In the last 30 days Quantisnow tracked 1 wire item for YDES, including 1 press release or news item. The most recent was published Nov 12, 2026.

YDES FAQ

7 questions
  • What is YDES revenue?
    YD Bio Limited (YDES) reported $596.8K of revenue for fiscal 2025 (ended Dec 31, 2025). That is up 16.9% from the year before.
  • Is YDES profitable?
    No. YD Bio Limited reported a net loss of $8.31M for fiscal 2025 (ended Dec 31, 2025).
  • How much cash and debt does YDES have?
    YD Bio Limited reported $6.01M in cash and cash equivalents and $6.8K of debt on its most recent balance sheet in SEC filings.
  • Where does YDES stock trade?
    YD Bio Limited (YDES) is listed on NASDAQ.
  • What sector and industry is YDES in?
    YD Bio Limited operates in the Health Care sector, Medical Specialities industry.
  • What companies are similar to YDES?
    Notable peers in the same industry include ILMN (Illumina Inc.), CI (The Cigna Group), LH (Labcorp Holdings Inc.), ELV (Elevance Health Inc.), UNH (UnitedHealth Group Incorporated). Compare YDES side-by-side with any of them on Quantisnow.
  • How can I track YDES on Quantisnow?
    Quantisnow aggregates YD Bio Limited's SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow YDES to receive live email and push alerts on every new disclosure.

Is something on this page wrong, or out of date? Request a change